VANECK ETF TR (BBH) - 5i Research

VANECK ETF TR (BBH $165.18)
- $165.18 P/E (TTM): 120.08X Cap: $347M
- View BBH Profile
- View Questions on BBH

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

iShares Biotechnology ETF (IBB $138.22)
- $138.22 P/E (TTM): 74.16X Cap: $5.64B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $24.09)
- $24.09 Cap: $9.37B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $165.18)
- $165.18 P/E (TTM): 120.08X Cap: $347M
- View BBH Profile
- View Questions on BBH

Q: Currently not invested in this sector. Considering starting a position in this company. Appreciate your insights.
Thank you

Read Answer Asked by Larry on September 07, 2023

iShares Biotechnology ETF (IBB $138.22)
- $138.22 P/E (TTM): 74.16X Cap: $5.64B
- View IBB Profile
- View Questions on IBB
CRISPR Therapeutics AG (CRSP $51.83)
- $51.83 Cap: $4.71B
- View CRSP Profile
- View Questions on CRSP
VANECK ETF TR (BBH $165.18)
- $165.18 P/E (TTM): 120.08X Cap: $347M
- View BBH Profile
- View Questions on BBH

Q: I am down by 55% on this company, although it is a small position (.8%) & I consider it speculative. Your comments will help me decide to wait, sell, or buy more. Thanks

Read Answer Asked by Louisa on March 30, 2023

Regeneron Pharmaceuticals Inc. (REGN $580.70)
- $580.70 P/E (TTM): 14.61X Cap: $61.54B
- View REGN Profile
- View Questions on REGN
Johnson & Johnson (JNJ $177.17)
- $177.17 P/E (TTM): 18.95X Cap: $426.68B
- View JNJ Profile
- View Questions on JNJ
Eli Lilly and Company (LLY $732.58)
- $732.58 P/E (TTM): 59.61X Cap: $693.35B
- View LLY Profile
- View Questions on LLY
Merck & Company Inc. (MRK $84.12)
- $84.12 P/E (TTM): 12.26X Cap: $210.11B
- View MRK Profile
- View Questions on MRK
Pfizer Inc. (PFE $24.76)
- $24.76 P/E (TTM): 17.94X Cap: $140.77B
- View PFE Profile
- View Questions on PFE
Thermo Fisher Scientific Inc (TMO $492.72)
- $492.72 P/E (TTM): 28.5X Cap: $186.05B
- View TMO Profile
- View Questions on TMO
Novo Nordisk A/S (NVO $56.46)
- $56.46 P/E (TTM): 16.03X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
iShares Biotechnology ETF (IBB $138.22)
- $138.22 P/E (TTM): 74.16X Cap: $5.64B
- View IBB Profile
- View Questions on IBB
Moderna Inc. (MRNA $24.09)
- $24.09 Cap: $9.37B
- View MRNA Profile
- View Questions on MRNA
VANECK ETF TR (BBH $165.18)
- $165.18 P/E (TTM): 120.08X Cap: $347M
- View BBH Profile
- View Questions on BBH
iShares U.S. Pharmaceuticals ETF (IHE $71.16)
- $71.16 P/E (TTM): 63.66X Cap: $583M
- View IHE Profile
- View Questions on IHE

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023